SUDA
Suda Ltd (ASX: SUD) is a drug delivery company utilising proprietary oro-mucosal drug delivery technology to develop low-risk, innovative pharmaceuticals that improve the health and lifestyle of patients. The many potential benefits of administering drugs through the oral mucosa, which is the moist lining of the oral cavity (ie: cheeks, tongue, gums and palate), include ease of use, lower dosage, reduced side effects and faster response time.
SUDA
Industry:
Biotechnology Lifestyle Pharmaceutical
Founded:
1982-01-01
Address:
Osborne, New South Wales, Australia
Country:
Australia
Website Url:
http://www.sudaltd.com.au
Total Employee:
101+
Status:
Active
Contact:
61 8 6142 5555
Total Funding:
9.5 M USD
Technology used in webpage:
Domain Not Resolving
Similar Organizations
1200 Pharma
1200 Pharma is a medicinal chemistry technology company that accelerates pre-clinical drug discovery and clinical approval timelines.
Advaxis
Advaxis is a developer of multiple cancer immunotherapies based on its proprietary platform that redirects the immune system to kill cancer.
Apellis Pharmaceuticals
Apellis Pharmaceuticals focuses on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.
EpiVax
EpiVax is an immunology company developing comprehensive analytical capabilities in the field of computational immunology.
Recro Pharma
Recro Pharma is a pharmaceutical company developing non-opioid therapeutics for the treatment of pain.
Salix Pharmaceuticals
Salix Pharmaceuticals is a specialty pharmaceutical company focused on the prevention and treatment of gastrointestinal disorders.
Current Employees Featured
Stephen Carter CEO @ Suda
CEO
Stock Details
More informations about "Suda"
Suda - Crunchbase Company Profile & Funding
Suda Ltd (ASX: SUD) is a drug delivery company utilising proprietary oro-mucosal drug delivery technology to develop low-risk, innovative pharmaceuticals that improve the health and …See details»
SUDA LIMITED Overview | SignalHire Company Profile
SUDA LIMITED is a private company. The company currently specializes in the Pharmaceuticals area. The number of employees ranges from 1 to 25See details»
Suda - Overview, News & Similar companies | ZoomInfo.com
Popular Searches SUDA Ltd Suda Pharmaceuticals Ltd Suda Acn 090 987 250 SUDA Pharmaceuticals Ltd ASX: SUD SIC Code 28,283 NAICS Code 32,325 Ticker ASX: SUD …See details»
For personal use only - asx.com.au
/ ANNUAL REPORT 2018 SUDA PHARMACEUTICALS LTD (PREVIOUSLY SUDA LTD) 04 AND CONTROLLED ENTITIES / ABN 35 090 987 250 REVIEW OF OPERATIONS KEY …See details»
SUDA PHARMACEUTICALS LTD - aspecthuntley.com.au
Suda pharmaceuticals limited (asx:sud) annual report 3 contents corporate directory 4 letter from the chairman 5 review of operations and activities 6 directors’ report 9 auditor’s independence …See details»
SUDA LTD: INVESTOR PRESENTATION For personal use only
SUDA LTD Tel: +61 8 6142 5555 sjcarter@sudaltd.com.au NOTES TO EDITORS: About SUDA LTD SUDA LTD (ASX: SUD) is a drug delivery company focused on oro-mucosal …See details»
Suda Limited, Level 1, Unit 12, 55 Howe...
Pharmaceuticals, Biotechnology & Life Sciences SUDA Ltd (ASX: SUD) is a drug delivery company utilising its proprietary OroMist® oro-mucosal drug delivery technology to develop …See details»
Suda Pharmaceuticals Ltd - MTPConnect
About Suda Ltd SUDA Pharmaceuticals Ltd (SUDA), based in Australia and the US, is a world leader in reformulating and delivering medication through the oral mucosa. Patients typically …See details»
SUDA LTD COMPLETES SUCCESSFUL $5.3 MILLION CAPITAL RAISING
SUDA LTD Tel: +61 8 6142 5555 sjcarter@sudaltd.com.au NOTES TO EDITORS: About SUDA LTD SUDA LTD (ASX: SUD) is a drug delivery company focused on oro-mucosal …See details»
SUDA LTD PUBLISHES SHAREHOLDER NEWSLETTER - asx.com.au
Sep 13, 2016 SUDA LTD Tel: +61 8 6142 5555 sjcarter@sudaltd.com.au NOTES TO EDITORS:About SUDA LTD SUDA LTD (ASX: SUD) is a drug delivery company focused on …See details»
SUDA LTD - Techboard
SUDA LTD. 25/03/2016 01/11/2023 Rafael Kimberley-Bowen Health & biotech. Company Owned Profile: No. Login to Take Ownership. Company Profile; Company Announcements: (reported …See details»
Suda’s Competitors, Revenue, Number of Employees, Funding
Suda’s Profile, Revenue and Employees. Suda is a drug-delivery pharmaceutical company that focuses on developing oro-mucosal sprays. Suda’s primary competitors include Altus …See details»
Suda Pharmaceuticals Ltd (ASX:SUD) Share Price - Market Index
Suda Pharmaceuticals Ltd (SUD, formerly Suda Ltd) is a drug delivery company utilising proprietary oro-mucosal drug delivery technology to develop low-risk, innovative …See details»
SUDA PHARMACEUTICALS LTD (SUD) - InvestoGain
SUDA LTD: 07/12/2012: 05/12/2017: EASTLAND MEDICAL SYSTEMS LTD: 07/12/2012: Shareholder links. Our website ranking of SUD: (3 out of 5) COMPANY WEBSITE: SUD …See details»
SUDA LTD PUBLISHES QUARTERLY NEWSLETTER For personal use …
SUDA LTD Tel: +61 8 6142 5555 sjcarter@sudaltd.com.au NOTES TO EDITORS: About SUDA LTD SUDA LTD (ASX: SUD) is a drug delivery company focused on oro-mucosal …See details»
Companies and organisations | ASIC
Use ASIC's Organisations and Business Names search to find information on companies, registered bodies, foreign companies, and other types of entities. Visit ASIC's website for more …See details»
SUDA LTD (ASX.SUD) | InvestoGain Australia
The securities of Suda Ltd will be reinstated to official quotation immediately following the release of an announcement regarding negotiations with the estate of HC Berlin Pharma. 27/02/2017: …See details»
SUDA becomes Arovella Therapeutics, plans to capitalise on …
Proactive Investors Australia Pty Ltd ACN 132 787 654 (the Company, we or us) provides you with access to the content set out above, including any news, quotes, information, data, text, …See details»
SUDA GRANTED AFRICAN PATENT FOR ARTIMIST ANTI …
Property Organization (ARIPO), which is an intergovernmental organisation for cooperation among African states in intellectual property matters. ARIPO comprises 19 ... SUDA LTD Tel: …See details»
SUDALTD$ENTERS$INTO$LICENCE$AND$COLLABORATION
ASX$Release$No.$752$ 8January$2015$ Page1$of$3$ $ $ $ $ $$$$$ACN$090$987$250$ ASX$Release$ $ SUDALTD$ENTERS$INTO$LICENCE$AND$COLLABORATION$See details»